PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Orthopedic Biologics Supply Partner in Port St. Lucie, FL

Precision Biologics distributes perinatal-derived Wharton's jelly and exosome products to licensed orthopedic practices and surgery centers in Port St. Lucie, Florida. Every account is verified against an NPI number, and product documentation is shared with confirmed buyers on request. Clinical use and dosing decisions remain the responsibility of the treating physician and counsel.

REGISTRY DATA / FL

Port St. Lucie

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

13
Orthopaedic Surgery
13
Source: NPPES NPI Registry ↗

How Precision Biologics supports new accounts in Florida

A Port St. Lucie orthopedic practice opening an account works through NPI verification first, then receives access to product specifications, certificates of analysis, and donor eligibility summaries for the formats under consideration. A peer-to-peer call is available to walk through documentation, not clinical guidance.

From there, most practices move to a first order once internal purchasing sign-off is complete, with lot-level records available for the patient file on receipt.

Shipping into the Southeast region

Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers; a Port St. Lucie practice receiving these should have freezer capacity and a staff member who logs the shipment against its lot identifier on arrival. Lyophilized formats are shelf-stable and do not require cryogenic storage.

Carrier networks serving Southeast Florida generally support overnight delivery for cold-chain shipments, though a practice should confirm its own receiving hours and freezer readiness before a first order ships.

Documentation and Florida regulatory context

We recommend a Port St. Lucie practice confirm any planned use with its medical director and separately verify current requirements with the Florida Board of Medicine (or Board of Osteopathic Medicine, as applicable) and its own counsel. Florida's SB 1768, effective July 1, 2025, permits MD/DO physicians to use certain non-FDA-approved stem cell therapies in orthopedics, wound care, and pain management with informed consent and specific disclosures, but it does not override federal FDA rules governing any individual product.

Precision Biologics does not interpret SB 1768 for a practice; that determination belongs to the practice's own counsel.

Vendor qualification for orthopedic practices and surgery centers

Orthopedic groups and ambulatory surgery centers typically review a new biologics vendor's registration and licensure documentation, a sample certificate of analysis, and lot-release and recall procedures before adding a product to formulary. Precision Biologics makes this documentation available to verified accounts and does not publish clinical protocols.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Does Florida's SB 1768 mean these products are FDA approved?+

No. SB 1768 addresses how certain Florida-licensed physicians may use non-FDA-approved stem cell therapies under state law; it does not change federal FDA status, and these products remain subject to FDA regulation and are not FDA approved.

How does a Port St. Lucie surgery center open an account?+

The center submits its NPI number and delivery location, completes a short verification step, and gains access to pricing and documentation once confirmed.

What should a Port St. Lucie practice check before a first cold-chain shipment?+

Confirm freezer capacity, a designated receiving contact, and delivery hours that match overnight dry-ice carrier schedules for the Southeast region.